331 related articles for article (PubMed ID: 32102520)
1. Progesterone Receptor Expression in the Benign Prostatic Hyperplasia and Prostate Cancer Tissues, Relation with Transcription, Growth Factors, Hormone Reception and Components of the AKT/mTOR Signaling Pathway.
Spirina LV; Kovaleva IV; Usynin EA; Goorbunov AK; Kondakova IV
Asian Pac J Cancer Prev; 2020 Feb; 21(2):423-429. PubMed ID: 32102520
[TBL] [Abstract][Full Text] [Related]
2. VHL Expression in Kidney Cancer: Relation to Metastasis Development, Transcription and Growth Factors and Component of Akt/m-TOR Signaling Pathway.
Spirina LV; Kondakova IV; Yurmazov ZA; Usynin EA; Slonimskaya EM; Lushnikova NA; Podnebesnova DV
Bull Exp Biol Med; 2019 Sep; 167(5):671-675. PubMed ID: 31625068
[TBL] [Abstract][Full Text] [Related]
3. Reception of Sex Steroid Hormones in Thyroid Papillary Cancer Tissue and Relationship with Expression and Content of Transcription Factors Brn-3α and TRIM16.
Spirina LV; Chizhevskaya SY; Kondakova IV; Choinzonov EL
Bull Exp Biol Med; 2018 Dec; 166(2):237-240. PubMed ID: 30488195
[TBL] [Abstract][Full Text] [Related]
4. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
[TBL] [Abstract][Full Text] [Related]
5. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.
Chen R; Yu Y; Dong X
J Steroid Biochem Mol Biol; 2017 Feb; 166():91-96. PubMed ID: 27125450
[TBL] [Abstract][Full Text] [Related]
7. ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1.
Mak P; Li J; Samanta S; Mercurio AM
Oncotarget; 2015 Nov; 6(37):40247-54. PubMed ID: 26450901
[TBL] [Abstract][Full Text] [Related]
8. Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancer.
Cai C; Jiang FN; Liang YX; He HC; Han ZD; Dai QS; Qin GQ; Chen JH; Chen XB; Chen YR; Zeng GH; Zhu JG; Zhong WD
Pathol Oncol Res; 2011 Dec; 17(4):873-8. PubMed ID: 21499820
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
[TBL] [Abstract][Full Text] [Related]
10. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
11. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
[TBL] [Abstract][Full Text] [Related]
12. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
13. [Transcription factors NF-kB, HIF-1, HIF-2, growth factor VEGF, VEGFR2 and carboanhydrase IX mRNA and protein level in the development of kidney cancer metastasis].
Spirina LV; Usynin YA; Yurmazov ZA; Slonimskaya EM; Kolegova ES; Kondakova IV
Mol Biol (Mosk); 2017; 51(2):372-377. PubMed ID: 28537244
[TBL] [Abstract][Full Text] [Related]
14. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer.
Pungsrinont T; Kallenbach J; Baniahmad A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681745
[TBL] [Abstract][Full Text] [Related]
15. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.
Nanni S; Benvenuti V; Grasselli A; Priolo C; Aiello A; Mattiussi S; Colussi C; Lirangi V; Illi B; D'Eletto M; Cianciulli AM; Gallucci M; De Carli P; Sentinelli S; Mottolese M; Carlini P; Strigari L; Finn S; Mueller E; Arcangeli G; Gaetano C; Capogrossi MC; Donnorso RP; Bacchetti S; Sacchi A; Pontecorvi A; Loda M; Farsetti A
J Clin Invest; 2009 May; 119(5):1093-108. PubMed ID: 19363294
[TBL] [Abstract][Full Text] [Related]
16. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
18. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling.
Deep G; Gangar SC; Oberlies NH; Kroll DJ; Agarwal R
Mol Carcinog; 2010 Oct; 49(10):902-12. PubMed ID: 20721970
[TBL] [Abstract][Full Text] [Related]
19. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
20. Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation.
Goyal A; Poluzzi C; Willis CD; Smythies J; Shellard A; Neill T; Iozzo RV
J Biol Chem; 2012 Dec; 287(52):43543-56. PubMed ID: 23060442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
